I would agree, but I'd certainly like to know more about the specifics of their trials. The company chooses not to provide the information that would normally be found in the clinical trials database, so much of what they're doing remains a mystery.

I believe they've put together a team of amazing people who looking at their experience have great prior success in common, but they also have something else, they build companies and sell them off at great profit to themselves, and the investors. While I believe the company has the potential of something I'd want to hold for a decade or more, I suspect their time frame is more like a few years, and I hope by then the company won't be bought out for less than $3 billion.

Gary